Author: admin

  • Kate Hoey – 2014 Parliamentary Question to the Department of Health

    Kate Hoey – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Kate Hoey on 2014-07-16.

    To ask the Secretary of State for Health, what steps his Department is taking to engage with the public about (a) care.data and (b) ways of opting-out of care.data before data is collected.

    Dr Daniel Poulter

    NHS England is currently listening to the views of patients, the general public, general practitioners (GPs) and stakeholders on how best to further build trust and confidence in the care.data programme. Local stakeholders, including GPs, patients, the general public and health and care representatives, are taking part in debates and workshops to air their views.

    There will be a phased approach to implementation. NHS England intends to work with a number of GP practices, ‘pathfinders’, in the autumn to test, evaluate and refine all aspects of the data collection process ahead of national roll-out. This will include consideration of ways of objecting “opting out” to being included in the care.data programme.

    A care.data advisory group has been established to support the programme and that group will also be involved in shaping the pathfinder stage. Ciaran Devane, Chief Executive of Macmillan Cancer Support and a non-executive director of NHS England, has agreed to chair the group.

  • John McDonnell – 2014 Parliamentary Question to the Department of Health

    John McDonnell – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by John McDonnell on 2014-07-16.

    To ask the Secretary of State for Health, what payments have been received by the NHS in return for the advertising of Optical Express services on the NHS Choices website.

    Dr Daniel Poulter

    NHS Choices does not advertise services on their website. Optical Express is included within the service directory published on NHS Choices on the basis that it is a provider of NHS services.

    NHS Choices has neither sought nor received any payment from Optical Express in return for this inclusion.

  • Jim Dobbin – 2014 Parliamentary Question to the Department of Health

    Jim Dobbin – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Dobbin on 2014-07-16.

    To ask the Secretary of State for Health, pursuant to the Answers of 9 July 2014, Official Report, column 313W, on ovarian cancer and 24 June 2014, Official Report, columns 156-7W, on ovarian hyperstimulation syndrome, if his Department will collect data on the number of women admitted to hospital with ovarian hyperstimulation syndrome (OHSS); if he will take steps to ensure systematic reporting of OHSS from egg sharing and egg donation; if he will make it his policy that ovarian hyperstimulation syndrome be notifiable; and if he will take steps to ensure that women are accurately informed of the risk of hospitalisation from OHSS when considering egg donation or egg sharing procedures.

    Jane Ellison

    Collection of data relating to treatments regulated by the Human Fertilisation and Embryology Act 1990, as amended, and the recording of serious adverse clinical reactions come within the statutory duties of the Human Fertilisation and Embryology Authority (HFEA).

    At its meeting on 9 July 2014, the HFEA agreed a new strategy for 2014-2017, which sets out its regulatory focus. Also at that meeting, the Authority members agreed to give consideration to the collection of additional data when a case of Ovarian Hyperstimulation Syndrome is reported. The HFEA will take expert scientific and medical advice on whether such data collection would be of value and on the feasibility of collecting reliable information.

    The papers for the meeting and an audio record of the discussions can be found on HFEA’s website at:

    www.hfea.gov.uk/Authority-July-2014.html

  • Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Grahame M. Morris on 2014-07-16.

    To ask the Secretary of State for Health, what contractual arrangement is in place between the Hospital Corporation of America (HCA) and St Bartholomew’s Hospital Trust regarding (a) ownership of the Gamma Knife and (b) leases that HCA may have in relation to the property.

    Jane Ellison

    We are advised that three senior neurosurgery consultants are responsible for the Gamma Knife operation at St Bartholomew’s Hospital, along with one neuro interventional radiologist and two clinical oncologists. All are employed by Barts Health NHS Trust, and are overseen by the Clinical Director for Neurosciences and the Group Director for Emergency Care and Acute Medicine, both of whom are clinicians.

    HCA employs one senior administrator, the Acting Chief Operating Officer for the Harley Street Clinic, along with the physicist and nursing staff and an administration co-ordinator who work in the Gamma Knife centre at St Bartholomew’s Hospital.

    We are advised that HCA owns the Gamma Knife based at St Bartholomew’s Hospital and that HCA pays a rental fee to Barts Health NHS Trust.

    We understand that, as the Gamma Knife was purchased by HCA, St Bartholomew’s Hospital (then part of Barts and The London NHS Trust) incurred minimal set up costs for the establishment of the service in 2009. This included costs for associated building work to accommodate the facility.

    Gamma Knife surgery is funded by NHS England as the commissioner for all specialist services. We are advised that Barts Health NHS Trust receives approximately £9,200 per patient from NHS England and that HCA charges Barts Health £7,310 per patient treated by the Gamma Knife facility at St Bartholomew’s Hospital.

    If the hon. Member wishes to obtain further information about the Gamma Knife facility at St Bartholomew’s Hospital, he may wish to contact Barts Health NHS Trust directly.

  • Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Grahame M. Morris on 2014-07-16.

    To ask the Secretary of State for Health, how much St Bartholomew’s Hospital Trust invested in the establishment of its Gamma Knife Centre in 2009; what the source of such funding was; and how much of that investment has since been recouped.

    Jane Ellison

    We are advised that three senior neurosurgery consultants are responsible for the Gamma Knife operation at St Bartholomew’s Hospital, along with one neuro interventional radiologist and two clinical oncologists. All are employed by Barts Health NHS Trust, and are overseen by the Clinical Director for Neurosciences and the Group Director for Emergency Care and Acute Medicine, both of whom are clinicians.

    HCA employs one senior administrator, the Acting Chief Operating Officer for the Harley Street Clinic, along with the physicist and nursing staff and an administration co-ordinator who work in the Gamma Knife centre at St Bartholomew’s Hospital.

    We are advised that HCA owns the Gamma Knife based at St Bartholomew’s Hospital and that HCA pays a rental fee to Barts Health NHS Trust.

    We understand that, as the Gamma Knife was purchased by HCA, St Bartholomew’s Hospital (then part of Barts and The London NHS Trust) incurred minimal set up costs for the establishment of the service in 2009. This included costs for associated building work to accommodate the facility.

    Gamma Knife surgery is funded by NHS England as the commissioner for all specialist services. We are advised that Barts Health NHS Trust receives approximately £9,200 per patient from NHS England and that HCA charges Barts Health £7,310 per patient treated by the Gamma Knife facility at St Bartholomew’s Hospital.

    If the hon. Member wishes to obtain further information about the Gamma Knife facility at St Bartholomew’s Hospital, he may wish to contact Barts Health NHS Trust directly.

  • Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    Grahame M. Morris – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Grahame M. Morris on 2014-07-16.

    To ask the Secretary of State for Health, what the revenue division is between the Hospital Corporation of America and St Bartholomew’s Hospital Trust London for fees charged to NHS England for treating NHS patients on the Gamma Knife housed in St Bartholomew’s Hospital.

    Jane Ellison

    We are advised that three senior neurosurgery consultants are responsible for the Gamma Knife operation at St Bartholomew’s Hospital, along with one neuro interventional radiologist and two clinical oncologists. All are employed by Barts Health NHS Trust, and are overseen by the Clinical Director for Neurosciences and the Group Director for Emergency Care and Acute Medicine, both of whom are clinicians.

    HCA employs one senior administrator, the Acting Chief Operating Officer for the Harley Street Clinic, along with the physicist and nursing staff and an administration co-ordinator who work in the Gamma Knife centre at St Bartholomew’s Hospital.

    We are advised that HCA owns the Gamma Knife based at St Bartholomew’s Hospital and that HCA pays a rental fee to Barts Health NHS Trust.

    We understand that, as the Gamma Knife was purchased by HCA, St Bartholomew’s Hospital (then part of Barts and The London NHS Trust) incurred minimal set up costs for the establishment of the service in 2009. This included costs for associated building work to accommodate the facility.

    Gamma Knife surgery is funded by NHS England as the commissioner for all specialist services. We are advised that Barts Health NHS Trust receives approximately £9,200 per patient from NHS England and that HCA charges Barts Health £7,310 per patient treated by the Gamma Knife facility at St Bartholomew’s Hospital.

    If the hon. Member wishes to obtain further information about the Gamma Knife facility at St Bartholomew’s Hospital, he may wish to contact Barts Health NHS Trust directly.

  • Rosie Cooper – 2014 Parliamentary Question to the Department of Health

    Rosie Cooper – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Rosie Cooper on 2014-07-16.

    To ask the Secretary of State for Health, how many Lancashire residents were admitted to a mental health unit that was not their nearest facility in urgent or emergency situations because of a lack of beds since April 2012; how many such patients lived in West Lancashire constituency; and how much has been spent on private sector provision for such patients.

    Norman Lamb

    The data is not collected centrally.

    Information on out of area placements for mental health patients in Lancashire and the costs of private sector provision for such patients may be obtained from NHS England’s Cheshire, Warrington and Wirral Area Team.

    Patients may be referred out of area for specialised mental health treatment for a number of reasons. In all cases, places will be found in the nearest possible facility.

  • Ian Lucas – 2014 Parliamentary Question to the Department of Health

    Ian Lucas – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Lucas on 2014-07-16.

    To ask the Secretary of State for Health, how many beds in each UK spinal cord injury centre are ring fenced for the exclusive treatment of spinal cord injured readmissions or outpatients.

    Jane Ellison

    NHS England’s Spinal Cord Injuries (SCI) service specification clearly sets out what providers must have in place to offer evidence-based, safe and effective services. It sets a core requirement that each specialised SCI Centre (SCIC) can demonstrate they have a minimum of 20 beds dedicated exclusively for the treatment and rehabilitation of SCI patients. Specialised SCI Services encompass all activity for SCI patients provided by the host trust of the SCIC, including any readmission or attendance for SCI-related care, wherever the treatment is located in the trust. A copy of the specification can be found at the following link:

    www.england.nhs.uk/wp-content/uploads/2014/04/d13-spinal-cord-0414.pdf

    NHS England is aware that a number of beds in one ward at Stoke Mandeville spinal injuries unit are being used as escalation beds by medical specialties to assist with patient flow. It is planned for these beds to re-open as specialist spinal beds from September 2014.

  • Mark Williams – 2014 Parliamentary Question to the Department of Health

    Mark Williams – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Mark Williams on 2014-07-16.

    To ask the Secretary of State for Health, what training on the potential risks of opioid substitution treatment medications is provided to pharmacists, social workers and health visitors.

    Jane Ellison

    There is robust clinical guidance on substitute prescribing, which covers the timing and circumstances under which people with opiate dependency may be allowed to take home and be responsible for their opioid substitution medicine.

    It is for the professional bodies of pharmacists, social workers and health visitors to set the standards that training equips professionals to meet, and for employers to ensure that staff who are involved in or might encounter opioid substitution treatment are trained in its potential risks, including to children.

  • Ian Lucas – 2014 Parliamentary Question to the Department of Health

    Ian Lucas – 2014 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Ian Lucas on 2014-07-16.

    To ask the Secretary of State for Health, how many beds in each UK spinal cord injury centre have been ring fenced for the treatment of spinal cord injured readmissions or outpatients in each of the last five years.

    Jane Ellison

    NHS England’s Spinal Cord Injuries (SCI) service specification clearly sets out what providers must have in place to offer evidence-based, safe and effective services. It sets a core requirement that each specialised SCI Centre (SCIC) can demonstrate they have a minimum of 20 beds dedicated exclusively for the treatment and rehabilitation of SCI patients. Specialised SCI Services encompass all activity for SCI patients provided by the host trust of the SCIC, including any readmission or attendance for SCI-related care, wherever the treatment is located in the trust. A copy of the specification can be found at the following link:

    www.england.nhs.uk/wp-content/uploads/2014/04/d13-spinal-cord-0414.pdf

    NHS England is aware that a number of beds in one ward at Stoke Mandeville spinal injuries unit are being used as escalation beds by medical specialties to assist with patient flow. It is planned for these beds to re-open as specialist spinal beds from September 2014.